Development and Evaluation of a Novel Drug Delivery System for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains a significant global health challenge, with the need for innovative treatment strategies becoming increasingly urgent. The development and evaluation of novel drug delivery systems for targeted cancer therapy have emerged as a promising approach to enhance the efficacy and reduce the side effects of anticancer drugs. This thesis presents a comprehensive investigation into the design, development, and evaluation of a novel drug delivery system tailored for targeted cancer therapy. The introduction provides an overview of the current challenges in cancer treatment, emphasizing the limitations of conventional chemotherapy and the potential benefits of targeted drug delivery systems. The background of the study explores the existing literature on drug delivery systems in cancer therapy, highlighting the importance of targeted delivery for improved therapeutic outcomes. The problem statement identifies the gaps in current cancer treatment approaches and underscores the need for innovative drug delivery systems to address these limitations. The objectives of the study are outlined to guide the research towards developing a novel drug delivery system that can effectively target cancer cells while minimizing off-target effects. The limitations and scope of the study are discussed to provide clarity on the boundaries and constraints of the research. The significance of the study is emphasized, highlighting the potential impact of developing an efficient and targeted drug delivery system for improving cancer treatment outcomes. The structure of the thesis is outlined to provide a roadmap for the subsequent chapters. The literature review delves into ten key aspects of drug delivery systems in cancer therapy, including nanoparticle-based delivery systems, ligand-targeted delivery approaches, and the role of nanotechnology in enhancing drug delivery efficiency. The research methodology chapter details the experimental design, materials, and methods used in developing and evaluating the novel drug delivery system. Chapter four presents a detailed discussion of the findings, including the characterization of the developed drug delivery system, in vitro and in vivo evaluation studies, and comparisons with existing drug delivery approaches. The results are critically analyzed, and the implications for targeted cancer therapy are discussed in depth. Finally, chapter five provides a comprehensive conclusion and summary of the thesis, highlighting the key findings, contributions to the field, and future directions for research. Overall, this thesis contributes to the advancement of targeted cancer therapy through the development and evaluation of a novel drug delivery system that holds promise for improving treatment outcomes and patient quality of life.